Advertisement
Advertisement

CMMB

CMMB logo

Chemomab Therapeutics Ltd. - ADR

1.34
USD
+0.03
+2.67%
Apr 28, 15:49 UTC -4
Closed
exchange

After-Market

1.39

+0.04
+2.97%

Chemomab Therapeutics Ltd. - ADR Profile

About

Chemomab Ltd. is a clinical-stage biotech company. It focuses on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need. The company's product pipeline includes CM-101. Chemomab Ltd., formerly known as Anchiano Therapeutics Ltd., is based in TEL-AVIV, Israel.

Info & Links

CEO

Adi Mor

Headquarters

KIRYAT ATIDIM, BUILDING 7
TEL AVIV, L3 6158002, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.chemomab.com

Auditor

Somekh Chaikin

Share holders

7

Employees

16

Chemomab Therapeutics Ltd. - ADR Statistics

Valuation Measures

Market Capitalization2

26.12M

Enterprise Value

19.97M

Enterprise Value/EBITDA(ttm)

-1.35

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.05

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-101.70%

Return on Invested Capital(ttm)

-108.61%

Return on Assets(ttm)

-76.18%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-14.74M

Net Income Available to Common(ttm)

-13.95M

Diluted EPS(ttm)

-1.00

Share Statistics

Beta (5Y Monthly)

0.66

52-Week Change

110.19%

S&P 500 52-Week Change

8.06%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

18.86M

Dividend Yield

0.00%

Float4

12.65M

% Held by Insiders

11.91%

% Held by Institutions

46.05%

Balance Sheet

Total Cash(mrq)

14.34M

Total Cash Per Share(mrq)

0.76

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.98%

Quick Ratio(mrq)

4.57%

Book Value Per Share(mrq)

0.72

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.86

Free Cash Flow(ytd)

-15.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement